Plant MedicineEmerging Evidence

Ibogaine

Also known as: Iboga, Tabernanthe iboga

Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of the Tabernanthe iboga shrub, native to Central West Africa. The Bwiti tradition of Gabon has used iboga in spiritual initiation ceremonies for centuries. Ibogaine is studied mainly for opioid and other substance us...

Applications

6

Clinical Trials

3

Evidence Tier

emerging

Duration

8-12 hours acute effects, with subtle aftereffects lasting 24-72 hours

Overview

Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of the Tabernanthe iboga shrub, native to Central West Africa. The Bwiti tradition of Gabon has used iboga in spiritual initiation ceremonies for centuries. Ibogaine is studied mainly for opioid and other substance use disorders; observational studies report that a single treatment can reduce opioid withdrawal symptoms and cravings, but there are no completed randomized controlled trials. Researchers think it acts on several neurotransmitter systems, including dopamine, serotonin and opioid receptors. A typical ibogaine experience lasts 8-12 hours and involves a waking dream state with intense introspection, life review, and often vivid visions addressing the psychological origins of addiction. A 2024 Stanford study of 30 special operations veterans with traumatic brain injury (Nature Medicine), with no control group, reported large drops in PTSD, depression and anxiety symptoms one month after ibogaine given with magnesium. Ibogaine carries serious cardiac risks, including QT interval prolongation and fatal arrhythmias, and deaths have been reported. In 2025 Texas set aside $50 million for ibogaine clinical trials. As of October 2026, ibogaine is not FDA-approved for any use.

Traditional Use

Used for generations in the Bwiti spiritual tradition of Gabon and Cameroon for initiation rites, healing ceremonies, and communion with ancestors. Iboga is protected as cultural heritage in Gabon.

Therapeutic Applications

Opioid addiction (heroin, prescription opioids)Alcohol use disorderStimulant addiction (methamphetamine, cocaine)PTSD and traumaDepression and anxietyTraumatic brain injury (emerging research)

Clinical Trials

Texas Ibogaine Clinical Trial Program (SB 2308)

Funded - Not Yet Recruiting
PhasePlanned
InstitutionState of Texas (funded 2025)

Ibogaine for Traumatic Brain Injury in Veterans

Completed - Published 2024
PhaseObservational
InstitutionStanford University

Ibogaine for Opioid Dependence

Completed
PhaseObservational
InstitutionMAPS

Risks & Contraindications

Potential Risks

  • •Cardiac arrhythmias and QT interval prolongation (potentially fatal)
  • •Seizures in vulnerable individuals
  • •Intense nausea and physical discomfort
  • •Psychological distress during experience
  • •Ataxia and coordination difficulties post-treatment
  • •Drug interactions with numerous medications
  • •Fatalities reported, primarily from cardiac complications or poly-drug use

Contraindications

  • Cardiovascular disease or family history of sudden cardiac death
  • Long QT syndrome
  • Liver or kidney disease
  • Pregnancy and breastfeeding
  • Concurrent use of most medications (requires supervised withdrawal)
  • Active psychosis
  • Severe malnutrition

Safety screening

Psychedelics are not safe for everyone. Talk with a licensed clinician first, especially if any of these apply to you:

  • Antidepressants such as SSRIs and SNRIs, and other medicines that raise serotonin (tramadol, for example): they can blunt the effect of psychedelics, and with some substances, such as MDMA and ayahuasca, raise the risk of serotonin syndrome.
  • Lithium: seizures have been reported when lithium is combined with classic psychedelics such as psilocybin and LSD.
  • MAOIs, including the MAOIs in ayahuasca: dangerous interactions with many medicines, other substances and some foods.
  • Heart disease, high blood pressure, or a heart rhythm problem such as long QT syndrome.
  • A personal or family history of psychosis, schizophrenia or bipolar disorder.
  • Pregnancy or breastfeeding.

Never stop or change a prescribed medicine without your prescriber.

Gabriel doesn't give psychedelic dosing and doesn't help anyone obtain psychedelics. This page explains research and risks; it is not medical advice.

If you're in crisis, call or text 988 (Suicide and Crisis Lifeline). For a medical emergency, call 911.

Legal Status

Legal status as of October 2026. Laws change; check the current law where you live. This is not legal advice.

United States

Schedule I federally with no approved medical use. In 2025 Texas set aside $50 million for ibogaine clinical trials (SB 2308); that funds research and does not make ibogaine legal to use.

International

Not approved or regulated in Mexico, which does not make it legal treatment there. Prescription-only in South Africa and New Zealand, and allowed by prescription in São Paulo state, Brazil. Portugal decriminalized personal possession of all drugs in 2001. Illegal in many other countries.

Key Researchers

Deborah Mash (University of Miami)Thomas Kingsley Brown (UC San Diego)Kenneth Alper (NYU)Geoff Noller (UCSD)Eduardo Schenberg (Brazil)

Key Studies

  • 1Noller et al. - Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study (2018)
  • 2Brown et al. - Ibogaine and subjective experience: Transformative states and psychopharmacotherapy in the treatment of opioid use disorder (2019)
  • 3Cherian et al. - Magnesium-ibogaine therapy in veterans with traumatic brain injuries (Nature Medicine, 2024)

Quick Facts

CategoryPlant Medicine
Evidence TierEmerging
Duration8-12 hours acute effects, with subtle aftereffects lasting 24-72 hours

Questions? Ask Gabriel

Gabriel can help you find and book licensed clinicians who offer ketamine or esketamine treatment. Gabriel doesn't prescribe ketamine.

Ask Gabriel

Related Substances

Ayahuasca

Ayahuasca is a traditional Amazonian brew, usually made from the Banisteriopsis caapi vine and Psychotria viridis leaves. The vine contains harmala alkaloids that act as MAO inhibitors (MAOIs), which let the DMT in the leaves become active when swallowed, producing a visionary experience that usually lasts 4 to 6 hours. Indigenous peoples of the Amazon have used ayahuasca for generations in ceremonies for healing, spiritual guidance and community ritual. A small randomized trial in Brazil (2019) found that a single dose reduced depression scores in people with treatment-resistant depression compared with placebo, and observational studies have looked at ayahuasca for substance use disorders. Because the brew contains MAOIs, it can interact dangerously with antidepressants and many other medicines and substances. The experience usually involves vomiting and diarrhea, which traditional practitioners consider part of the ceremony.

ModerateLearn more →

Peyote / Mescaline

Peyote (Lophophora williamsii) is a small, spineless cactus containing mescaline as its primary psychoactive alkaloid. Sacred to the Native American Church (NAC), which has over 400,000 members across 50+ tribes, peyote serves as a holy sacrament in all-night ceremonies for spiritual communion, healing, and addressing personal and social imbalances. The NAC originated around 1885 among Kiowa and Comanche tribes, blending indigenous spirituality with Christian elements to preserve peyote traditions during persecution. Ceremonies occur in tipis around a crescent-shaped altar and sacred fire, running from Saturday evening through Sunday morning. Participants consume peyote (never smoked, only eaten dry, ground, or as tea) with prayer, singing, and contemplation, seeking guidance, healing, and communion with God and spirits. The Peyote Spirit is considered a deity providing visions, promoting brotherly love, family care, steady work, and abstinence from alcohol. Peyote contains more than 50 alkaloids; anthropologists have described sobriety as a goal of many Native American Church members, but controlled clinical research is minimal. Peyote is also a slow-growing, threatened cactus, and Native American Church leaders have asked non-Native people not to seek it out. The experience typically lasts 10-12 hours with enhanced perception, emotional openness, and spiritual insight.

TraditionalLearn more →

San Pedro / Huachuma

San Pedro (Echinopsis pachanoi), known as Huachuma in indigenous traditions, is a mescaline-containing cactus native to the Andes mountains of Peru, Bolivia, Ecuador, and surrounding regions. With over 4,000 years of ceremonial use, it is one of the oldest entheogens in the Americas, predating psilocybin mushroom use. Archaeological evidence from Peru's Chavín culture (1500 BCE) shows stone carvings of shamans holding the cactus. The Inca used San Pedro in ceremonies at Cusco, Machu Picchu, and the Sacred Valley for spiritual communion with deities, purification, divination, healing, and governance counsel. The primary psychoactive compound, mescaline, increases prefrontal cortex activity for emotional regulation and planning while producing heart-opening, empathogenic effects alongside visual enhancements. Traditional curanderos (healers) in Peru and Ecuador use San Pedro tea in blended indigenous-modern medicine for shamanic healing, enhancing perception, awakening intuition, and diagnosing mind-body-spirit imbalances. The experience, lasting 10-14 hours, typically brings euphoria, compassion, empathy, enhanced environmental awareness, and insights into personal problems. Modern clinical research on mescaline is very limited, so these traditional uses have not been tested in controlled trials.

TraditionalLearn more →